On the contrary, another study reported that increased infiltration of tumor tissue by T cells in RCC patients is associated with shorter survival, but the higher proliferative activity of CD8(+) T cells in contact with tumor cells is linked to longer survival, highlighting the importance of considering the effectiveness of antitumor immunity in immunotherapy approaches [18]. This evidence concerns the gene CD8A and renal cell adenocarcinoma.